205 related articles for article (PubMed ID: 34797182)
1. Stratification of atopic dermatitis patients by patterns of response to proactive therapy with topical tacrolimus: low serum IgE levels and inadequately controlled disease activity at the start of treatment predict its failure.
Kasai H; Kawasaki H; Fukushima-Nomura A; Yasuda-Sekiguchi F; Amagai M; Ebihara T; Tanese K
Ann Med; 2021 Dec; 53(1):2205-2214. PubMed ID: 34797182
[TBL] [Abstract][Full Text] [Related]
2. Topical tacrolimus for atopic dermatitis.
Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
[TBL] [Abstract][Full Text] [Related]
3. Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis.
Siegfried EC; Jaworski JC; Kaiser JD; Hebert AA
BMC Pediatr; 2016 Jun; 16():75. PubMed ID: 27267134
[TBL] [Abstract][Full Text] [Related]
4. A Comparison of Topical Corticosteroids and Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis.
Pena J; Zameza PA; Pixley JN; Remitz A; Feldman SR
J Allergy Clin Immunol Pract; 2023 May; 11(5):1347-1359. PubMed ID: 36997119
[TBL] [Abstract][Full Text] [Related]
5. Topical treatment utilization for patients with atopic dermatitis in the United States, and budget impact analysis of crisaborole ointment, 2.
Clark R; Bozkaya D; Levenberg M; Faulkner S; Smith TW; Gerber RA
J Med Econ; 2018 Aug; 21(8):770-777. PubMed ID: 29706103
[TBL] [Abstract][Full Text] [Related]
6. Potential preventive effects of proactive therapy on sensitization in moderate to severe childhood atopic dermatitis: A randomized, investigator-blinded, controlled study.
Fukuie T; Hirakawa S; Narita M; Nomura I; Matsumoto K; Tokura Y; Ohya Y
J Dermatol; 2016 Nov; 43(11):1283-1292. PubMed ID: 27075216
[TBL] [Abstract][Full Text] [Related]
7. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.
Wollenberg A; Reitamo S; Atzori F; Lahfa M; Ruzicka T; Healy E; Giannetti A; Bieber T; Vyas J; Deleuran M;
Allergy; 2008 Jun; 63(6):742-50. PubMed ID: 18445188
[TBL] [Abstract][Full Text] [Related]
8. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.
Wollenberg A; Reitamo S; Girolomoni G; Lahfa M; Ruzicka T; Healy E; Giannetti A; Bieber T; Vyas J; Deleuran M;
Allergy; 2008 Jul; 63(7):742-50. PubMed ID: 18592619
[TBL] [Abstract][Full Text] [Related]
9. The role of topical calcineurin inhibitors in atopic dermatitis.
Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
[TBL] [Abstract][Full Text] [Related]
10. Topical tacrolimus in adult atopic dermatitis: a consensus based on a 15-year experience.
Calzavara-Pinton P; Fabbrocini G; Girolomoni G; Matiucci A; Micali G; Musumeci ML; Patruno C; Pellacani G; Rossi MT; Castello M; Stingeni L
G Ital Dermatol Venereol; 2020 Feb; 155(1):8-13. PubMed ID: 31760730
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials.
Schmitt J; von Kobyletzki L; Svensson A; Apfelbacher C
Br J Dermatol; 2011 Feb; 164(2):415-28. PubMed ID: 20819086
[TBL] [Abstract][Full Text] [Related]
12. Reduction of serum TARC levels in atopic dermatitis by topical anti-inflammatory treatments.
Yasukochi Y; Nakahara T; Abe T; Kido-Nakahara M; Kohda F; Takeuchi S; Hagihara A; Furue M
Asian Pac J Allergy Immunol; 2014 Sep; 32(3):240-5. PubMed ID: 25268342
[TBL] [Abstract][Full Text] [Related]
13. A practical algorithm for topical treatment of atopic dermatitis in the Middle East emphasizing the importance of sensitive skin areas.
Reda AM; Elgendi A; Ebraheem AI; Aldraibi MS; Qari MS; Abdulghani MMR; Luger T
J Dermatolog Treat; 2019 Jun; 30(4):366-373. PubMed ID: 30222017
[No Abstract] [Full Text] [Related]
14. Off-label topical calcineurin inhibitor use in children.
Manthripragada AD; Pinheiro SP; MaCurdy TE; Saneinejad S; Worrall CM; Kelman JA; Graham DJ
Pediatrics; 2013 Nov; 132(5):e1327-32. PubMed ID: 24127469
[TBL] [Abstract][Full Text] [Related]
15. Systematic review on the efficacy, safety, and cost-effectiveness of topical calcineurin inhibitors in atopic dermatitis.
Chia BK; Tey HL
Dermatitis; 2015; 26(3):122-32. PubMed ID: 25984688
[TBL] [Abstract][Full Text] [Related]
16. Topical clofibrate improves symptoms in patients with atopic dermatitis and reduces serum TARC levels: a randomized, double-blind, placebo-controlled pilot study.
Fukaya M; Kimata H
J Drugs Dermatol; 2014 Mar; 13(3):259-63. PubMed ID: 24595568
[TBL] [Abstract][Full Text] [Related]
17. Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study.
Thaçi D; Reitamo S; Gonzalez Ensenat MA; Moss C; Boccaletti V; Cainelli T; van der Valk P; Buckova H; Sebastian M; Schuttelaar ML; Ruzicka T;
Br J Dermatol; 2008 Dec; 159(6):1348-56. PubMed ID: 18782319
[TBL] [Abstract][Full Text] [Related]
18. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.
Pacor ML; Di Lorenzo G; Martinelli N; Mansueto P; Rini GB; Corrocher R
Clin Exp Allergy; 2004 Apr; 34(4):639-45. PubMed ID: 15080819
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors.
Tennis P; Gelfand JM; Rothman KJ
Br J Dermatol; 2011 Sep; 165(3):465-73. PubMed ID: 21466537
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials.
Ashcroft DM; Dimmock P; Garside R; Stein K; Williams HC
BMJ; 2005 Mar; 330(7490):516. PubMed ID: 15731121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
